DNA Methylation in Neurodegenerative Diseases


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

Epigenetic modifications in neurodegenerative diseases are just beginning to be studied; however, the growing interest in this phenomenon indicates its great importance in molecular mechanism of diseases and their phenotypical realization. DNA methylation takes one of the central places in gene expression regulation. This review considers the main DNA methylation types and the mechanisms of methylation and demethylation and provides general information on epigenetic regulation in Alzheimer’s disease, Parkinson’s disease, amyotrophic lateral sclerosis, Huntington’s disease, and hereditary ataxias. Possible prospects for targeted epigenetic correction as a new approach to neurodegenerative disease therapy are discussed.

About the authors

E. Yu. Fedotova

Research Center of Neurology

Author for correspondence.
Email: ekfedotova@gmail.com
Russian Federation, Moscow, 125367

S. N. Illarioshkin

Research Center of Neurology

Email: ekfedotova@gmail.com
Russian Federation, Moscow, 125367

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2019 Pleiades Publishing, Inc.